id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-E-0079-0008,FDA,FDA-2009-E-0079,Notice of Final Determination - Letter,Other,Letter(s),2012-04-17T04:00:00Z,2012,4,2012-04-17T04:00:00Z,,2012-04-17T12:07:42Z,,0,0,0900006480ff1c2f
FDA-2009-E-0079-0007,FDA,FDA-2009-E-0079,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-02-23T05:00:00Z,2011,2,2011-02-23T05:00:00Z,,2011-02-23T20:47:53Z,,0,0,0900006480bf667d
FDA-2009-E-0079-0006,FDA,FDA-2009-E-0079,Determination of Regulatory Review Period for Purposes of Patent Extension: TOVIAZ,Notice,N-Notice,2010-04-06T04:00:00Z,2010,4,2010-04-06T04:00:00Z,2010-06-08T03:59:59Z,2010-04-06T16:09:56Z,2010-07679,0,0,0900006480ad0824
FDA-2009-E-0079-0005,FDA,FDA-2009-E-0079,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-24T04:00:00Z,2010,3,2010-03-24T04:00:00Z,,2013-08-11T03:07:34Z,,0,0,0900006480ac78db
FDA-2009-E-0079-0004,FDA,FDA-2009-E-0079,U.S. Patent and Trademark Office to FDA/CDER - Letter,Other,LET-Letter,2009-12-08T05:00:00Z,2009,12,2009-12-08T05:00:00Z,,2013-08-11T03:05:48Z,,0,0,0900006480a666a2
FDA-2009-E-0079-0003,FDA,FDA-2009-E-0079,FDA/CDER to the U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2009-10-01T04:00:00Z,2009,10,2009-10-01T04:00:00Z,,2009-10-01T18:11:42Z,,0,0,0900006480a36434
FDA-2009-E-0079-0001,FDA,FDA-2009-E-0079,USPTO to FDA/CDER - Letter,Other,LET-Letter,2009-02-18T05:00:00Z,2009,2,2009-02-18T05:00:00Z,,2009-02-18T15:52:00Z,,0,0,090000648085dcbb
FDA-2009-E-0079-0002,FDA,FDA-2009-E-0079,Schwarz Pharma AG - Patent Term Extension Application,Other,APP-Application,2009-02-18T05:00:00Z,2009,2,2009-02-18T05:00:00Z,,2013-07-27T22:38:28Z,,0,0,090000648085df57